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Abstract
Background: The evolution of fertility treatment methods such as laparoscopic surgery and assisted reproductive technology (ART)
leads to an increased chance for conception in women with endometriosis. However, it is still not clear which treatment is more
likely to result in endometriosis recurrence.
Objectives: The current study aimed at assessing the recurrence rate of endometriosis and its main determinants following fertility
treatment with surgery or ART.
Methods: The current historical cohort study was conducted on 51 consecutive women with endometriosis undergoing fertilization
procedures, including laparoscopic surgery (n = 42) and ART (n = 9) in Tehran from 2006 to 2016. All patients with complete hospital
records were enrolled in the study. The patients in the two groups were followed up for five years for endometriosis recurrence.
Results: Within the follow-up time, the rate of endometriosis recurrence in patients of the surgery and ART groups was 28.6% and
44.4%, respectively, indicating no significant difference between the groups (P = 0.436). In this regard, the 1-, 2-, and 3-year recurrence-
free survival rate in the ART group was 87.5%, 50.0%, and 50.0%, and in the surgery group was 96.9%, 90.6%, and 70.5%, respectively.
Using the Cox proportional hazard modeling adjusted for baseline variables, the method of fertilization (ART or surgery) could not
affect the rate of long-term recurrence of endometriosis (odds ratio = 1.428, 95% confidence interval: 0.177 - 9.900, P = 0.784).
Conclusions: The method of fertilization treatment-e g, surgery, and ART- may not affect the rate of endometriosis recurrence in
women with subfertility caused by endometriosis.
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1. Background
Infertility of women with endometriosis is today’s
challenge in women’s fertility. According to a global es-
timation, about 25% - 35% of women with infertility have
endometriosis, and up to 50% with endometriosis are
infertile. Additionally, about 8% of women candidates
for assisted reproductive technology (ART) are diagnosed
with endometriosis (1). More than two-thirds of women
with endometriosis who underwent controlled ovarian
hyper-stimulation require higher total doses of ovulation-
stimulation drugs to increase the likelihood of concep-
tion; however, the rate of clinical pregnancy, particularly
in severe cases, remains considerably low (2, 3). Var-
ious reasons raised for the high infertility rate among
women with endometriosis such as distorted pelvic struc-
ture, endocrine-related ovulatory abnormalities, activated
inflammatory cascades, altered peritoneal environment,
abnormal uterine bleeding (AUB), and impaired uterine
implantation (4-6). Apart from a low conception rate in
the background of endometriosis due to its detrimental
impact on ovarian responsiveness to hyper-stimulation, its
adverse effects on the outcome of pregnancy are notewor-
thy. Endometriosis can increase the risk of ectopic preg-
nancy by 30% - 40% (7). The increased risk of preterm la-
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bor, small for gestational age, hemorrhagic complications,
spontaneous rupture or perforation of utero-ovarian ves-
sels during pregnancy, and also miscarriages are also pro-
posed (8-10). The consequences of ART in women with en-
dometriosis are different from those of the ones without
it. Endometriosis is accompanied by a lower number of
retrieved oocytes as well as a higher rate of cycle cancella-
tion (11). However, there is a fundamental question about
the association between ovulation induction and the risk
of endometriosis progression and recurrence. The con-
trolled ovarian hyper-stimulation may increase the risk of
endometriosis recurrence due to increased estradiol con-
centration (12); however, some authors contrarily noted no
increased risk of a new endometrioma following the con-
trolled ovarian hyper-stimulation (13). Because of the close
relationship between endometriosis and infertility, as well
as the adverse impact of endometriosis on fertility after dif-
ferent fertility treatments, the incidence of endometriosis
decreases following fertility treatment.
2. Objectives
The present study aimed at assessing the recurrence of
endometriosis and its main determinants following fertil-
ity treatment with surgery or ART.
3. Methods
The current historical cohort study was performed on
all consecutive women with endometriosis undergoing
fertility treatments, including laparoscopic surgery or ART
in two large hospitals in Tehran in 10 years from 2006 to
2016. All patients with complete hospital records, includ-
ing demographic characteristics, clinical history, charac-
teristics of endometriosis, and outcomes of ovulation in-
duction, were eligible for the present study. Women with
the following features were excluded: onset of pain imme-
diately after delivery, spontaneous pregnancy, symptoms
caused by other clinical conditions, and evidence of my-
oma or other abdominopelvic masses. By reviewing the
hospital records, study variables including demographic
and socioeconomic characteristics, number of parity and
history of abortion, grade, and symptoms of endometrio-
sis, and anthropometric indices were extracted and trans-
ferred to the checklist. The patients in the two groups
were followed up for five years through both physical ex-
amination (to assess the change in clinical manifestations)
and sonography assessment to assess endometriosis recur-
rence. Recurrence of endometriosis was defined as the
recurrence of pelvic pain (severity equal or greater than
pre-intervention) with palpated pelvic masses or nodula-
tions on pelvic examination and/or presence of ovarian
cysts with the typical sonographic findings of endometri-
omas larger than 20 mm in diameter. In this regard, the
recurrence-free survival rate was compared between the
two groups, matched by baseline variables. For statistical
analysis, IBM SPSS version 21.0 was employed (IBM Corp.
2012. Armonk, NY: IBM Corp.). Baseline characteristics be-
tween the two groups were compared using the student or
the Mann-Whitney test whenever the data did not appear
to have a normal distribution or when the assumption of
equal variances was violated across the study groups. Cat-
egorical variables were compared using the chi-squared
test. Results were expressed as numbers and percentages
for categorical variables or mean ± standard deviation
(SD) for quantitative variables. Cox proportional hazard
analysis was used to determine the difference in recur-
rence of endometriosis between the methods of fertiliza-
tion including ART and surgery in the presence of baseline
variables including age, body mass index (BMI), education
level, occupational status, stage of endometriosis, number
of parity, and history of abortion, and the results were pre-
sented as hazard ratio (HR) and 95% confidence interval for
HR. P values less than 0.05 were considered statistically sig-
nificant.
4. Results
The two study groups included patients undergoing
ART (n = 9) or surgery (n = 42). As summarized in Table
1, there was no significant difference in baseline variables
including mean BMI, education level, occupational status,
number of parity or abortion, history of ectopic pregnancy,
and number of children between the two groups; however,
the candidates for ART were significantly younger than
the ones undergoing surgery. Regarding the stage of en-
dometriosis, stage I was found in 19.1% and 22.2%, stage II
in 26.2% and 22.2%, stage III in 9.6% and 11.1%, and stage
IV in 45.2% and 44.4% of the ART and surgery groups, re-
spectively with no significant difference (P = 0.991). Within
the follow-up time, the rate of endometriosis recurrence
was 28.6% and 44.4% in the surgery and ART groups, re-
spectively, indicating no significant difference between
the groups (P = 0.436). In this regard, the 1-, 2-, and 3-year
recurrence-free rate was 87.5%, 50.0%, and 50.0% in the ART
group, and 96.9%, 90.6%, and 70.5% in the surgery group,
respectively (Figure 1). The mean time of recurrence in the
ART and surgery groups was 1.1 ± 0.6 and 2.3 ± 1.3 years,
respectively, indicating no significant difference between
the groups (P = 0.108). As shown in Table 2, there was no
significant difference in symptoms of endometriosis re-
currence, including chronic pelvic pain, dyspareunia, dy-
suria, dichasia, catheter-related pain, dysmenorrhea, and
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AUB between the groups. Using the Cox proportional haz-
ard modeling (Table 3) and baseline variables including
age, BMI, education level, occupational status, stage of en-
dometriosis, number of parity, and history of abortion, the
method of fertilization (ART or surgery) could not affect
the long-term recurrence rate of endometriosis (OR = 1.428,
95%CI: 0.177 - 9.900, P = 0.784).
Table 1. Baseline Characteristics of Patients Undergoing Fertility Treatment with ART
or Surgerya
Item ART Group (N = 9) Surgery Group (N
= 42)
P Value
Mean age, y 25.50 ± 3.89 32.56 ± 4.50 0.010
Mean BMI, kg/m2 25.50 ± 3.30 23.80 ± 3.81 0.242
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Figure 1. The endometriosis recurrence-free survival rate following ART or surgery
Table 2. Baseline Characteristics of Patients Undergoing Fertility Treatment with
ART or Surgery






Dyspareunia, % 33.3 11.9 0.137
Dysuria, % 22.2 4.8 0.139










The subfertility caused by endometriosis is a condition
identified several years ago; however, its pathogenesis re-
mains uncertain. In this regard, a high rate of subfertil-
ity is reported in women with endometriosis, and about
half of subfertile women have endometriosis. The evolu-
tion of fertility treatment methods such as laparoscopic
surgery and ART increased the chance of conception in
women with endometriosis. Another point in such a popu-
lation is the increased risk of recurrent endometriosis fol-
lowing fertility treatment that can lead to re-experiencing
infertility and increased risk of ovarian malignancy. How-
ever, it is still not clear which process of ovulation induc-
tion is more likely to result in endometriosis recurrence.
In the present study, there was no significant difference in
the recurrence of endometriosis between surgery and ART
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Table 3. Cox Proportional Hazard Model to Determine the Difference in the Recur-
rence Rate of Endometriosis
Variable P Value HR 5% for HR
Method of fertilization
ART (ref) 1.000
Surgery 0.784 1.428 0.177 - 9.900
Age, y 0.645 1.043 0.873 - 1.245
BMI, kg/m2 0.999 1.000 0.814 - 1.228
Education level
Illiterate (ref) 1.000
Primary school 0.445 1.618 0.471 - 5.560
Diploma 0.326 1.457 0.647 - 6.098
Academic education 0.227 1.789 0.459 - 5.123
occupational status
Employed (ref) 1.000
Self-employed 0.398 1.546 0.135 - 2.216
Housewife 0.228 1.478 0.122 - 3.120
Stage of endometriosis
I (ref) 1.000
II 0.448 1.277 0.680 - 2.398
III 0.328 1.358 0.328 - 3.457
IV 0.656 1.478 0.560 - 3.895
Number of parity
1 (ref) 1.000
2 0.394 1.593 0.546 - 4.650
3 0.452 1.785 0.458 - 3.898
4 0.392 1.329 0.224 - 3.863
History of abortion
No (ref) 1.000
Yes 0.389 0.589 0.176 - 1.967
as fertility treatments. In other words, the endometriosis
recurrence-free survival rate was similar in both fertility
treatment techniques. This result could be obtained even
after adjusting probable confounders such as the grade of
endometriosis, parity, and history of miscarriage. There-
fore, it seems that the main criteria for selecting the best
fertility treatment considering the risk of recurrent en-
dometriosis are the cost-efficacy, successful ovulation, and
patient’s satisfaction. In some recent trials, both fertil-
ity treatment methods were accompanied by a low recur-
rence rate of endometriosis. In a Cochrane review, four
randomized clinical trials showed that excisional surgery
of ovarian endometrioma led to a favorable outcome con-
sidering the recurrence of endometriosis symptoms and
subsequent spontaneous pregnancy in women who previ-
ously were infertile (14-17); however, there was no consen-
sus on the best surgical techniques to improve the success
rate of fertility treatment. In this regard, some studies em-
phasize the superiority of excision/stripping surgery over
the vaporization/coagulation technique due to a lower rate
of endometriosis recurrence (18), but some other authors
indicate ovarian cystectomy as the surgical choice versus
ablation (19). Another point is that the secondary surgery
can increase the risk of endometriosis recurrence com-
pared with the primary surgery, and thus, there is a direct
relationship between the number of surgeries and the rate
of endometriosis recurrence. Vercellini et al. (20), showed
that a lower conception rate is expected in patients under-
going a second surgery for recurrent endometriosis com-
pared with the ones who had a primary surgery (22% versus
40%). In this regard, some authors recommend in-vitro fer-
tilization instead of a secondary surgery that can preserve
the chance of conception (21).
Compared with surgical techniques, the impact of ap-
plying ART for fertilization in women with endometrio-
sis on disease recurrence remains questioned. Similar to
surgical interventions, selecting different ART regimens
results in different rates of endometriosis recurrence. A
study showed that preoperative hormonal treatment did
not reduce endometriosis-related pain and recurrence
(22), while in another study, the long-term adjuvant hor-
monal treatment led to the reduction of recurrence rate
(23). To the best of authors’ knowledge, the current study
was the first that compared the recurrence rate of en-
dometriosis in women undergoing surgery and ART for
fertility treatment and could show a similar recurrence
rate in both approaches. However, more studies on differ-
ent ART regimens and repeated surgical procedures are re-
quired.
In the current study, the rate of endometriosis recur-
rence was 28.6% and 44.4% in patients undergoing surgery
and ART, respectively, indicating no significant difference
between the groups (P = 0.436). A wide range of recur-
rence rates is reported in various studies from 6% to 67%
(24, 25) that might be due to different definitions for en-
dometriosis recurrence, follow-up time, and severity of
primary endometriosis (26-28). As indicated in the cur-
rent study, none of the baseline variables, including the
method of fertilization (ART or surgery), patients’ age or
BMI, stage of endometriosis, and the number of parity or
history of abortion could predict disease recurrence. Re-
viewing the literature showed that history of endometrio-
sis surgery, bilateral pelvic involvement of endometriotic
lesions, ovarian endometrioma, tenderness, younger age,
history of medication, and advanced-stage disease could
predict endometriosis recurrence after fertility treatment
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(24, 29). Authors believe that to obtain the main indica-
tors for the recurrence of endometriosis following ovula-
tion induction, providing a uniform definition for recur-
rence, and performing studies with larger sample sizes and
higher statistical power, especially for the adjustment of
confounders, seems essential.
5.1. Conclusions
The present study showed that the method of fertiliza-
tion, surgery, or ART, may not affect the rate of endometrio-
sis recurrence in women with subfertility caused by en-
dometriosis. In other words, each of these fertilization
methods may be selected to minimize the endometriosis
recurrence rate. However, other advantages and disadvan-
tages of these methods should be considered to obtain
more conclusive results.
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